SynaptixBio
PrivateLast Round
Grant
Aug 22, 2024
Total Funding Raised
$19.88M
Company Overview
SynaptixBio is a biotechnology company that develops gene silencing therapies for severe leukodystrophies and other childhood neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynaptixBio Comparables
Compare SynaptixBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vico Therapeutics | 78% | |
| Velvio GmbH | 78% | |
| Sinfonia Biotherapeutics | 71% |
SynaptixBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 22, 2024 | ||||
| Grant | Dec 23, 2023 | ||||
| Seed | Apr 28, 2023 | ||||
| Seed | Apr 1, 2021 |
SynaptixBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2024
$2.6M grant received from Innovate UK.
SynaptixBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SynaptixBio's valuation, stock price, and market status.
Is SynaptixBio a public or private company?
SynaptixBio is a private company.
What is the current stock price of SynaptixBio?
SynaptixBio is a private company with no public stock price. No recent secondary market data is available.
How much is SynaptixBio worth (valuation)?
Valuation information for SynaptixBio is not publicly available.
Can I buy SynaptixBio stock?
SynaptixBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SynaptixBio's last funding round?
SynaptixBio's most recent funding round was Grant on August 22, 2024.
Who are the main investors in SynaptixBio?
Key investors in SynaptixBio include Innovate UK.
Will SynaptixBio IPO soon?
No public IPO plans have been announced for SynaptixBio.
How can I track SynaptixBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SynaptixBio's secondary market activity and sign up for updates.